Clinical Trials Sponsored by Berendo Scientific, LLC

Total 239 results

Bayer
Janssen Scientific Affairs, LLC

Completed

Satisfaction/Quality of Life With Rivaroxaban in SPAF (Stroke Prevention in Atrial Fibrillation) Indication (SAFARI)

Atrial Fibrillation

France
Bayer
Janssen Scientific Affairs, LLC

Completed

Dose-confirmatory Bridging Study in Total Knee Replacement

Venous Thromboembolism

Japan
All4Cure
Janssen Scientific Affairs, LLC

Recruiting

Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma

Multiple Myeloma | Multiple Myeloma Without Mention of Remission

United States
Bayer
Janssen Scientific Affairs, LLC

Completed

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Non-valvular Atrial Fibrillation (NVAF)

Japan
Janssen Scientific Affairs, LLC
Bayer

Completed

Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants

Pharmacokinetics | Healthy Participants | Bioavailability

United States
Bayer
Janssen Scientific Affairs, LLC

Completed

Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism (BOX-AF)

Atrial Fibrillation

Belgium
Bayer
Janssen Scientific Affairs, LLC

Completed

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Deep Vein Thrombosis

Japan
Janssen Scientific Affairs, LLC
HCA Research Institute, LLC

Recruiting

A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population (IPACE-CVD)

Coronary Artery Disease (CAD) | Peripheral Artery Disease (PAD)

United States
Yale University
Janssen Scientific Affairs, LLC

Not yet recruiting

PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor (emo_to2)

Muscarinic Receptor Occupancy

United States
Janssen Scientific Affairs, LLC
Apple Inc.

Active, not recruiting

A Study to Investigate if Early Atrial Fibrillation (AF) Diagnosis Reduces Risk of Events Like Stroke in the Real-World

Atrial Fibrillation

United States
Duke University
Janssen Scientific Affairs, LLC

Completed

The Learning Registry

Atherosclerotic Cardiovascular Disease

United States
Ohio State University
Vascular Scientific, LLC

Completed

Dietary Supplementation in Heart Failure (R-DRINK)

Heart Failure

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

CONCERTA Lab School Study

Attention Deficit Hyperactivity Disorder

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females

Contraception
Therapeutic Concepts
Janssen Scientific Affairs, LLC

Unknown

Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects (PREZENT)

HIV Positive

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity
Ortho-McNeil Janssen Scientific Affairs, LLC

Terminated

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

Schizophrenia

United States, China, Colombia, Bulgaria, India, Malaysia, Russian Federation, Ukraine, Canada, Korea, Republic of, Brazil, Czech Republic
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Evaluation of Bacteria in the Mouth and Throat of Healthy Adults Before and After the Administration of Either Levofloxacin or Azithromycin, Both Antibiotic Medications

Healthy Volunteer
Augusta University
Janssen Scientific Affairs, LLC

Not yet recruiting

Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure

Multiple Myeloma | Renal Failure

United States
Northwestern University
Janssen Scientific Affairs, LLC

Active, not recruiting

An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses

Ichthyosis

United States
LifeBridge Health
Janssen Scientific Affairs, LLC

Unknown

Synergistic Influence of Rivaroxaban on Inflammation and Coagulation Biomarkers in Patients With CAD and PAD on Aspirin Therapy

Coronary Artery Disease | Peripheral Artery Disease

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Lab School Day Study for CONCERTA of Older Children With ADHD

Attention Deficit Hyperactivity Disorder

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

A Complicated Skin and Soft-tissue Infection Patient Registry

Abscess | Cellulitis | Staphylococcal Skin Infections | Surgical Wound Infection | Diabetic Foot Infections
Rockefeller University
Janssen Scientific Affairs, LLC

Withdrawn

Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.

Hidradenitis Suppurativa

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease

Psychotic Disorders | Schizophrenia | Schizoaffective Disorder

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Withdrawn

Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital

Schizophrenia
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal Women

Hot Flashes | Menopause
Ortho-McNeil Janssen Scientific Affairs, LLC

Terminated

The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia (POST)

Schizophrenia
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Oxycodone User Registry (OUR)

Pain
University of Pennsylvania
Janssen Scientific Affairs, LLC

Recruiting

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients (EVOLUTION)

Psoriatic Arthritis

United States
University of Pennsylvania
Janssen Scientific Affairs, LLC

Not yet recruiting

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients (EVOLUTION)

Psoriatic Arthritis

United States
NYU Langone Health
Janssen Scientific Affairs, LLC

Recruiting

Multi-Center PAMPA Study (PAMPA)

Psoriasis

United States, Canada
Thomas Jefferson University
Janssen Scientific Affairs, LLC

Active, not recruiting

Home Based Daratumumab Administration for Patients With Multiple Myeloma

Plasma Cell Myeloma

United States
University of Florida
Janssen Scientific Affairs, LLC

Completed

Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies

Coronary Artery Disease | Peripheral Arterial Disease | Atrial Fibrillation

United States
The Cleveland Clinic
Janssen Scientific Affairs, LLC

Terminated

CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes

Obesity | Diabetes Mellitus, Type 2

United States
Boston Medical Center
Janssen Scientific Affairs, LLC

Completed

Pharmacist-led Intervention on Adherence in Patients Undergoing Treatment With an Oral Oncology Medication (BSPAP)

Adherence, Medication

United States
University of Miami
Janssen Scientific Affairs, LLC

Withdrawn

Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma

Leiomyosarcoma
University of Arkansas
Janssen Scientific Affairs, LLC

Withdrawn

Predicting Clinical Response to Golimumab With Mucosal Barrier Dysfunction

Ulcerative Colitis
Heart Center Research, LLC
Boston Scientific Corporation

Recruiting

Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts (DART-HA)

Heart Failure, Congestive

United States
NYU Langone Health
Janssen Scientific Affairs, LLC

Completed

Cognitive Detection of Preclinical AD: Validation Using Biomarkers

Mild Cognitive Impairment

United States
Virginia Commonwealth University
Janssen Scientific Affairs, LLC

Completed

Treatment of Diabetes in Patients With Systolic Heart Failure

Diabetes Mellitus, Type 2 | Heart Failure, Systolic

United States
University of Pennsylvania
Janssen Scientific Affairs, LLC

Completed

Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U) (VIP-U)

Cardiovascular Disease | Psoriasis

United States
Johns Hopkins University
Janssen Scientific Affairs, LLC

Recruiting

Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)

Lupus Erythematosus, Systemic | Lupus Nephritis | SLE | Lupus | SLE (Systemic Lupus) | SLE Nephritis | SLE; Glomerulonephritis (Etiology)

United States
University of Washington
Janssen Scientific Affairs, LLC

Recruiting

Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study

Castration-Resistant Prostate Carcinoma | Prostate Adenocarcinoma

United States
East Carolina University
Janssen Scientific Affairs, LLC

Recruiting

Effect of Biktarvy & Symtuza on microRNAs in HIV and Correlation With Weight Gain

HIV Infections | Obesity

United States
University of Arkansas
Janssen Scientific Affairs, LLC

Recruiting

Treatment of POEMS Syndrome With Daratumumab

POEMS Syndrome

United States
George Washington University
Janssen Scientific Affairs, LLC

Completed

Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Ortho-McNeil Janssen Scientific Affairs, LLC
Bayer

Completed

Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement

Arthritis | Osteoarthritis, Knee | Thromboembolism | Osteoarthritis, Hip

United States
Boston Scientific Corporation
ICON plc

Completed

Maximizing CRT Delivery by Using MultipolAr Coronary Sinus Lead FamiLy ACUITY® X4 - RALLY X4 Study (RallyX4)

Heartfailure

Spain, Belgium, Netherlands, Hong Kong, Italy, France, Finland, Switzerland, Israel, Germany, United Kingdom, Colombia, Singapore, Denmark, Portugal, Japan, Austria, Ireland
Boston Scientific Corporation
ICON plc

Completed

Optimizing Pacing Therapy by Using Multi-Programmable Pulse Generators for Cardiac Resynchronization Pacing (CRT-P) (Rally CRT-P)

Post Market Surveillance Study Following Clinical Routine

Germany, Finland

Clinical Trials Sponsored by Berendo Scientific, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations